3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
9
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Turcot syndrome
1
Thyroid Neoplasms
1
Tertiary Lymphoid Structures
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Multiple Myeloma
1
Microsatellite Instability
1
Melanoma, Cutaneous Malignant
1
Interventions
Cyclophosphamide
32
Vincristine
22
blinatumomab
20
Methotrexate
20
Specimen Handling
19
Prednisone
19
Cytarabine
17
merphos
16
prednylidene
15
deltacortene
15
Biopsy
15
Mercaptopurine
14
Doxorubicin
14
Dexamethasone
14
N,N-dicyclohexyl-isoborneol-10-sulfonamide
13
pegaspargase
12
azathiopurine
12
Rituximab
12
Etoposide
12
dexamethasone acetate
11
dexamethasone 21-phosphate
11
auricularum
11
Spinal Puncture
11
Calcium Dobesilate
11
Asparaginase
11
Leucovorin
10
fludarabine
9
Magnetic Resonance Spectroscopy
9
Inotuzumab Ozogamicin
9
Daunorubicin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
relatlimab
×
90 days
×
Clear all
No trials found.